Detalhe da pesquisa
1.
Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data.
Eur J Pediatr
; 181(6): 2367-2378, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35275291
2.
Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults).
Pituitary
; 24(4): 622-629, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33742320
3.
Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
BMC Endocr Disord
; 20(1): 55, 2020 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32349731
4.
No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study.
BMC Endocr Disord
; 19(1): 138, 2019 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829160
5.
PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope® (somatropin) treatment in children: update on the United States cohort.
J Pediatr Endocrinol Metab
; 34(4): 431-440, 2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647196
6.
Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age.
Ther Adv Endocrinol Metab
; 12: 20420188211013121, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104396
7.
Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.
Horm Res Paediatr
; 94(3-4): 133-143, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350858
8.
Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study.
Ther Adv Endocrinol Metab
; 11: 2042018820943377, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32973992
9.
Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs.
Expert Opin Drug Saf
; 19(12): 1539-1548, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33089723
10.
Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
Horm Res Paediatr
; 93(3): 154-163, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814319
11.
Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy.
Ann Endocrinol (Paris)
; 80(4): 202-210, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910221
12.
Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY.
Ann Endocrinol (Paris)
; 76(6): 664-70, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596374